Stealth BioTherapeutics Competitors and Similar CompaniesClear all
Stealth BioTherapeutics's competitors and similar companies include Oxford BioTherapeutics and Orchard Therapeutics.
 Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. |  Oxford BioTherapeutics Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs. |  Orchard Therapeutics Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders. | |
Founding Date | Founding Date 2007 | Founding Date 2004 | Founding Date 2015 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Newton, US HQ Needham, US | Locations Milton, GB HQ San Jose, US | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US |
Employees | Employees 592% decrease | Employees 51 | Employees 166 |
Valuation ($) | Valuation ($) 18.4 m | Valuation ($) N/A | Valuation ($) 380.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £2.1m (FY, 2018) | Revenue (est.) $22.7m (FY, 2022) |
Net income | Net income ($52.5m) (FY, 2021) | Net income (£6.5m) (FY, 2018) | Net income ($150.7m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 21.6m | Total funding raised $ 310.7m |
For sources of this data, please see the company profile
View Company Profiles
Oxford BioTherapeutics
HQ
Milton, GB
Employees
51
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
View companyOrchard Therapeutics
HQ
London, GB
Employees
166
Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.
View company